Deferred Tax Assets, Net of Valuation Allowance of PHIBRO ANIMAL HEALTH CORP from 30 Jun 2013 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
PHIBRO ANIMAL HEALTH CORP quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 30 Jun 2013 to 30 Jun 2025.
  • PHIBRO ANIMAL HEALTH CORP Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 30 Jun 2025 was $58,330,000, a 48% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

PHIBRO ANIMAL HEALTH CORP Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $58,330,000 +$18,893,000 +48% 30 Jun 2025 10-K 27 Aug 2025 2025 FY
Q2 2024 $39,437,000 +$17,256,000 +78% 30 Jun 2024 10-K 27 Aug 2025 2025 FY
Q2 2023 $22,181,000 +$2,637,000 +13% 30 Jun 2023 10-K 28 Aug 2024 2024 FY
Q2 2022 $19,544,000 -$5,966,000 -23% 30 Jun 2022 10-K 30 Aug 2023 2023 FY
Q2 2021 $25,510,000 +$2,599,000 +11% 30 Jun 2021 10-K 24 Aug 2022 2022 FY
Q2 2020 $22,911,000 +$1,183,000 +5.4% 30 Jun 2020 10-K 25 Aug 2021 2021 FY
Q2 2019 $21,728,000 -$2,463,000 -10% 30 Jun 2019 10-K 26 Aug 2020 2020 FY
Q2 2018 $24,191,000 -$9,703,000 -29% 30 Jun 2018 10-K 27 Aug 2019 2019 FY
Q2 2017 $33,894,000 -$4,556,000 -12% 30 Jun 2017 10-K 27 Aug 2018 2018 FY
Q2 2016 $38,450,000 +$26,064,000 +210% 30 Jun 2016 10-K 30 Aug 2017 2017 FY
Q2 2015 $12,386,000 -$6,897,000 -36% 30 Jun 2015 10-K 29 Aug 2016 2016 FY
Q2 2014 $19,283,000 -$3,084,000 -14% 30 Jun 2014 10-K 10 Sep 2015 2015 FY
Q2 2013 $22,367,000 30 Jun 2013 10-K 18 Sep 2014 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.